Skip to content

An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract

An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract.

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02080702
Acronym
PROMEGAT
Enrollment
106
Registered
2014-03-06
Start date
2014-08-31
Completion date
2016-06-30
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C.Surgical Procedure; Digestive System, Gastric Anastomosis (Site), Gastrointestinal Neoplasms, Symptomatic Disorders of the Gastrointestinal Tract

Keywords

GIT, Monosyn, anastomoses leakage

Brief summary

The aim of this non-interventional study is to evaluate the efficacy of a monofilament, mid-term absorbable suture material (Monosyn®) for anastomosis performed in the gastrointestinal tract using the frequency of anastomosis leakage as a primary parameter. Postoperative complication rate, length of hospital stay, costs, time to perform the anastomosis and handling will serve as secondary endpoints. The question is addressed, whether a monofilament suture material is as effective as a braided suture material for anastomosis construction within the gastrointestinal tract.

Interventions

DEVICEMonosyn

Monosyn will be used to perform the gastrointestinal anastomoses

Sponsors

B.Braun Surgical SA
CollaboratorINDUSTRY
Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * ASA I-III * Indication for an elective tumor surgery within the GI tract (stomach, small intestine, large intestine) * Written informed consent

Exclusion criteria

* Emergency surgery * Peritonitis * Patients undergoing an operation due to a tumour within the pancreas, rectum, esophagus * Pregnant women and breast-feeding women * Chemotherapy * Current immunosuppressive therapy * Radiotherapy on the treated region within the last 2 months

Design outcomes

Primary

MeasureTime frameDescription
Frequency of anastomosis leakage rateparticipants will be followed for the duration of hospital stay, an expected average of 7 daysAnastomotic leak is defined as radiographic demonstration of a fistula or non-absorbable material drainage from a wound after oral administration, or visible disruption of the suture line during re-exploration.

Secondary

MeasureTime frameDescription
Reoperation rateparticipants will be followed for the duration of hospital stay, an expected average of 7 days
Length of hospital stayparticipants will be followed for the duration of hospital stay, an expected average of 10 daysDuration from day of operation until the day of discharge from the hospital.
Stay in the intensive care unitparticipants will be followed for the duration of hospital stay, an expected average of 7 daysDuration from the first day in the ICU until the last day in the ICU. In the case of readmission to the ICU the sum of all days within the ICU.
Postoperative complication rateparticipants will be followed for the duration of hospital stay, an expected average of 7 daysAs postoperative complications the following parameter will be documented: peritonitis, wound infection, bleeding, abscess, fistula, perforation, obstipation and stenosis. Wound infections, peritonitis and abscess are defined according to the Centres for Disease Control and Prevention (CDC, 17).
Costduration of the intervention (approximately 18 months)Calculation of the cost of material is based on the actual hospital costs for the suture material and the number of used threads by the surgeon. For the calculation of the operation costs, the time to perform the anastomosis will be multiplied with the cost of one operation minute (50-100 €).
Handling of the deviceEnd of the Study (approximately 18 months)Intra-operative handling of the suture material will be reported on a separate document one time per participating surgeon at the end of the study. The following criteria will be assessed: knot security, knot pull tensile strength, knot run-down, tissue drag, elasticity and feeling of the suture material. For the rating a 5-point scale is used
Duration to perform the anastomosisintraoperativelyThe time recorded for the construction of the anastomosis begins with the placement of the first stitch and ends with cutting the excess material from the last stitch.

Countries

Malaysia, Philippines, South Korea, Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026